期刊
CURRENT NEUROPHARMACOLOGY
卷 13, 期 3, 页码 294-303出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570159X13666150403231920
关键词
Clinical trials; NGF; NGF-healing action; treatment; NGF receptors; visual system
资金
- National Italian Research Council (CNR)
- Association NGF-ONLUS
- Ministry of Health
- Fondazione Roma
Nerve growth factor (NGF) is the firstly discovered and best characterized neurotrophic factor, known to play a critical protective role in the development and survival of sympathetic, sensory and forebrain cholinergic neurons. NGF promotes neuritis outgrowth both in vivo and in vitro and nerve cell recovery after ischemic, surgical or chemical injuries. Recently, the therapeutic property of NGF has been demonstrated on human cutaneous and corneal ulcers, pressure ulcer, glaucoma, maculopathy and retinitis pigmentosa. NGF eye drops administration is well tolerated, with no detectable clinical evidence of systemic or local adverse effects. The aim of this review is to summarize these biological properties and the potential clinical development of NGF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据